$33.78 $1.07 (3.3%)

04:30 PM EST on 01/28/20

Neogenomics Inc. (NASDAQ:NEO)

CAPS Rating: 4 out of 5

Current Price $33.78 Mkt Cap $3.4B
Open $33.02 P/E Ratio 1,497.50
Prev. Close $32.71 Div. (Yield) $0.00 (0.0%)
Daily Range $33.02 - $34.44 Volume 779,362
52-Wk Range $27.81 - $34.44 Avg. Daily Vol. 809,173

Caps

How do you think NASDAQ:NEO will perform against the market?

Add Stock to CAPS Watchlist

All Players

39 Outperform
13 Underperform
 

All-Star Players

5 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NEO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EnigmaDude (67.62)
Submitted September 07, 2012

Just starting to make a profit.Second Quarter 2012 Highlights:•57% test volume growth•49% revenue growth •58% gross profit growth•Net Income of $551,000, or $0.01 per share, vs. a loss of $(293,000), or ($0.01) per share in Q2 2011.•Adjusted EBITDA… More

TMFStockSpam (99.97)
Submitted March 16, 2010

This stock spam was originally sent to TMFBent:New York City – March 16, 2010 -- AMI Research, a leading provider of equity research reports and a division of IR Firm, Hawk Associates Inc., announced today that it has published updated stock research… More

NASDAQ:NEO VS S&P 500 (SPY)

NASDAQ:NEO Summary

Fools bullish on NASDAQ:NEO are also bullish on:

Fools bearish on NASDAQ:NEO are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NEO.

Recs

0
Member Avatar TMFBlacknGold (96.67) Submitted: 12/13/2019 10:34:11 AM : Outperform Start Price: $16.89 NASDAQ:NEO Score: +80.09

From 10/29/2019:

"NeoGenomics remains virtually the only dedicated oncology reference lab with a comprehensive testing menu. It continues to leverage its national footprint to serve 500,000 patients each year, a number that should grow as the business increases processing volumes. Then again, even without significant test volume growth, there's meaningful value to be unlocked by providing higher-quality data from the same biological samples. NeoGenomics is investing heavily in those capabilities -- and investors cannot overlook the significance."

https://www.fool.com/investing/2019/10/29/neogenomics-pours-money-into-next-generation-seque.aspx

Recs

0
Member Avatar EnigmaDude (67.62) Submitted: 9/10/2019 1:21:22 PM : Outperform Start Price: $21.44 NASDAQ:NEO Score: +47.52

Not sure why CFO suddenly resigned but showing pretty solid revenue growth of 50% YOY.

Recs

0
Member Avatar Turtlebale (49.61) Submitted: 8/16/2016 1:01:35 PM : Outperform Start Price: $8.01 NASDAQ:NEO Score: +272.07

attractive market

Leaderboard

Find the members with the highest scoring picks in NEO.

Score Leader

kenyon22

kenyon22 (34.42) Score: +927.76

The Score Leader is the player with the highest score across all their picks in NEO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kenyon22 34.42 10/1/2013 Outperform 5Y $3.01 +1,022.26% +94.50% +927.76 0 Comment
Bambi123 < 20 4/15/2014 Outperform 5Y $3.06 +1,003.92% +78.39% +925.53 0 Comment
XMFNpugs 46.06 7/24/2013 Outperform 5Y $3.30 +923.64% +93.48% +830.16 0 Comment
Ifpigscouldfly < 20 10/23/2013 Outperform 3Y $3.38 +899.85% +87.36% +812.50 0 Comment
franklyfoolish < 20 7/24/2013 Outperform 3Y $3.42 +887.72% +92.61% +795.11 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MajorBob04 99.60 4/3/2014 Outperform 5Y $3.71 +810.51% +72.88% +737.64 0 Comment
1OBNA 75.52 7/5/2013 Outperform 5Y $3.90 +766.15% +101.42% +664.73 1 Comment
cajun776 72.41 3/12/2013 Outperform 5Y $4.00 +744.50% +109.74% +634.76 0 Comment
Wpatrigo < 20 7/14/2014 Outperform 5Y $4.23 +698.58% +65.49% +633.09 0 Comment
JebBush 76.68 4/2/2015 Outperform 5Y $4.79 +605.22% +59.05% +546.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NEO.